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Abstract
Object—Approximately 20% of patients with an intracranial saccular aneurysm report a family
history of intracranial aneurysm (IA) or subarachnoid hemorrhage. A better understanding of
predictors of aneurysm detection in familial IA may allow more targeted aneurysm screening
strategies.
Methods—The Familial Intracranial Aneurysm (FIA) study is a multicenter study, in which the
primary objective is to define the susceptibility genes related to the formation of IA. First-degree
relatives (FDRs) of those affected with IA are offered screening with magnetic resonance (MR)
angiography if they were previously unaffected, are ≥ 30 years of age, and have a history of
smoking and/or hypertension. Independent predictors of aneurysm detection on MR angiography
were determined using the generalized estimating equation version of logistic regression.
Results—Among the first 303 patients screened with MR angiography, 58 (19.1%) had at least 1
IA, including 24% of women and 11.7% of men. Ten (17.2%) of 58 affected patients had multiple
aneurysms. Independent predictors of aneurysm detection included female sex (odds ratio [OR]
2.46, p = 0.001), pack-years of cigarette smoking (OR 3.24 for 20 pack-years of cigarette smoking
compared with never having smoked, p < 0.001), and duration of hypertension (OR 1.26
comparing those with 10 years of hypertension to those with no hypertension, p = 0.006).
Conclusions—In the FIA study, among the affected patients’ FDRs who are > 30 years of age,
those who are women or who have a history of smoking or hypertension are at increased risk of
suffering an IA and should be strongly considered for screening.
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Intracranial saccular aneurysms are acquired lesions, accounting for ~ 80% of all
nontraumatic SAHs. Several uncommon heritable disorders are associated with brain
aneurysms, including autosomal-dominant polycystic kidney disease,3 Marfan syndrome,17
Ehlers–Danlos syndrome Type IV,4 hereditary hemorrhagic telangiectasia,11
pseudoxanthoma elasticum, multiple endocrine neoplasia Type I, and neurofibromatosis
Type 1.16 Outside of these rare heritable disorders, population-based8,18 and nonpopulation-
based10,12–14 data suggest that there is an increased occurrence of IA and SAH in first- and
second-degree relatives of those with SAH, with the highest risk being noted in siblings.
Selected factors such as older age, female sex, history of hypertension, higher lipid levels,
and elevated blood glucose have been suggested to increase the possibility of aneurysm
detection in this setting.10,12
To clarify further the occurrence of IA detection on brain MR angiography studies in
families with several members affected, we report the initial results of MR angiography
screening of FDRs—siblings, parents, and children—of those affected with an IA in a
multicenter study of familial IA. We also report the predictors of IA detection on brain MR
angiography among these FDRs.
Clinical Materials and Methods
The FIA study is an international, multicenter study including 26 clinical centers, which
represents 41 recruitment sites in North America, New Zealand, and Australia.2 The study
was approved by the institutional review board/ethics committee at each of the study centers
and recruitment sites.
Families with multiple members in whom IAs were diagnosed were enrolled to identify the
chromosomal regions associated with an increased risk of IA and to determine the effects of
environmental factors on the expression of genes within these regions. Individuals with
either ruptured or unruptured IAs were considered to have the phenotype. Patients were
excluded if they had a fusiform IA; an intranidal aneurysm with an arteriovenous
malformation; a family history of polycystic kidney disease, Ehlers–Danlos syndrome,
Marfan syndrome, fibromuscular dysplasia, or moyamoya syndrome; or if informed consent
could not be obtained from the patient or family members.
Detailed medical records and the information acquired by telephone screening of probands
and family members with a reported history of IA or SAH were reviewed by the Verification
Committee. Two neurologists independently reviewed the records and determined if the
participant met all the inclusion and exclusion criteria. In cases of disagreement, a third
neurologist was consulted.
Definite, probable, and possible aneurysms were defined as follows. 1) Definite: medical
records document IA on cerebral angiogram, operative report, or autopsy, or a non-invasive
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imaging report (MR or CT angiography) demonstrates an IA measuring ≥ 7 mm in diameter.
2) Probable: death certificate notes an IA without supporting documentation or autopsy, or
notes an SAH without mention of aneurysm, and data obtained during telephone screening
are consistent with ruptured IA (severe headache or altered level of consciousness) rapidly
leading to death. A non-invasive imaging study documents an IA that is < 7 mm but > 3 mm
in diameter. 3) Possible: noninvasive imaging report documents an IA measuring between 2
and 3 mm in diameter. Death certificate notes an SAH without supporting documentation,
autopsy, or recording of headache or altered level of consciousness based on information
acquired during telephone screening. Death certificate lists “aneurysm” without specifying
cerebral location or accompanying SAH.
Data regarding important environmental risk factors were collected. Hypertension was
defined as a history of hypertension prior to the diagnosis of IA. The date of diagnosis of
hypertension was recorded. History of a diagnosis of diabetes or hypercholesterolemia was
recorded. Smoking history was recorded as ever/never/current smoker, and if the patient was
a current or former cigarette smoker, the number of pack-years prior to diagnosis of IA was
calculated. The number of alcoholic beverages consumed per day, cups of caffeinated coffee
per day, highest academic grade completed, and marital status were also noted.
The FDRs of those affected with IA were offered screening with MR angiography if they
were previously unaffected, ≥ 30 years of age, and had a history of smoking and/or
hypertension. The FIA Imaging Center at Mayo Clinic, Rochester, Minnesota, ensured that
high-quality MR angiography screening studies were performed at the imaging centers and
interpreted all imaging examinations that were performed as part of the FIA study. All FIA
enrolling and clinical centers were eligible to be imaging centers (see Appendix). Prior to
the imaging sessions for the individuals in this study, the centers underwent an accreditation
process, beginning with the center performing an MR angiography study as close to a
standardized sequence as appropriate, given the vendor and field strength of the MR unit.
Generally accepted parameters for intracranial MR angiography imaging have been
developed over time. To assist the imaging centers with the optimization of their MR
angiograms, an MR physicist and MR technologist were available for consultation at the
imaging center. Accredited imaging centers included General Electric, Philips, and Siemens
MR systems at 1.5-, 3.0-, and 4.0-T field strengths.
The imaging parameters for the standard protocol included a scout image of choice, a 3D
time-of-flight MR angiogram, and an axial T2-weighted fast spin echo sequence. The 3D
time-of-flight MR angiogram typically included 3 axial slabs of 32 sections per slab with
1.4-mm-thick sections, resulting in an imaging volume that included the posterior inferior
cerebellar arteries to the bifurcation of the pericallosal and callosal marginal arteries. The
axial fast spin echo T2-weighted sequence was performed with 4-mm-thick sections with
zero skip and included the same imaging volume as the MR angiography sequence. The fast
spin echo sequence was performed to exclude giant aneurysms with such slow flow that, due
to saturation effects, these lesions might not be depicted with standard MR angiography
imaging. Also, this allowed evaluation of the total size of partially thrombosed aneurysms.
On completing a trial of the standard protocol, the other imaging centers forwarded the study
in a DICOM format to the central FIA Imaging Center. Central imaging center review of the
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qualifying MR angiogram was performed to determine if changes to the imaging technique
were required prior to certification.
Accredited centers were eligible to obtain images in the patients and forwarded the
completed studies in a blinded manner to the imaging center. When received, the DICOM–
formatted studies were postprocessed by the imaging coordinator. Maximum intensity
projections of the MR angiogram were created to include the right carotid, left carotid, and
posterior circulations, with 10° rotations per image. Hard-copy films of the collapsed image,
maximum intensity projections, and fast spin echo images were created for archival
purposes.
Two experienced neuroradiologists at the imaging center reviewed all screening MR
angiograms, and cases were adjudicated to define the level of certainty of aneurysm
presence as outlined. Some patients had independently undergone MR or CT angiography
for their standard clinical care. These studies were also reviewed in a blinded manner by the
2 neuroradiologists.
After the imaging findings were interpreted by the 2 readers as concordant, the results were
forwarded to the Coordinating Center in Cincinnati. Cases requiring adjudication included
those for which the first reader detected an aneurysm that was not identified by the second
reader, aneurysms detected by both readers but at different anatomical sites, or aneurysms
identified by both readers in which the maximal measurement differed by > 1 mm. In these
cases, a consensus interpretation by the 2 readers was completed. If a consensus adjudication
could not be successfully accomplished, then an additional blinded interpretation by a third
experienced neuroradiologist was performed.
Statistical Analysis
An aneurysm was considered suitable as a case for the current analysis if the diameter was ≥
2 mm based on MR angiography findings; that is, was definite, probable, or possible. A
generalized estimating equation version of multiple logistic regression was used in these
analyses, with aneurysm case status as the binary outcome variable.9 The generalized
estimating equation model takes into account the lack of independence of outcomes within a
family by considering the members of each family as a cluster of correlated events. Several
potential risk factors were considered for possible inclusion in the model, as follows: patient
age, sex, history and duration of hypertension, smoking history and pack-years of cigarette
smoking, marijuana use, history and amount of alcohol use, history and amount of caffeine
consumption, estrogen replacement therapy, body mass index, history of diabetes or of
increased cholesterol, marital status, and educational level completed. Regression
diagnostics was used to assess the final model for collinearity.
Results
The MR angiography screening was performed in 303 patients, and of these 58 (19.1%) had
at least 1 aneurysm (Fig. 1). Overall, 71 aneurysms were detected, with multiple lesions
being detected in 10 (17.2%) of 58 patients: 1 had 4 IAs, 1 had 3 lesions, and 8 had 2. The
characteristics of those with and without an IA detected on MR angiography are summarized
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in Table 1. Women had an IA on MR angiography in 44 (24%) of 183 screening studies,
compared with 14 (11.7%) of 120 studies obtained in men. Those in whom an IA was
detected had a mean age of 53.7 years compared with 50.4 years for those with negative
findings on MR angiography. A history of current or prior cigarette smoking was present in
90% of those with IAs compared with 72% without lesions. The mean number of pack-years
of cigarette smoking was 27.4 in those with an IA, compared with 17.8 in those without an
IA. The duration of hypertension was 6.5 years in those with an IA, compared with 4.4 years
in those without an IA.
Numerous factors were evaluated as potential predictors of IA detection on MR angiography
screening. In the univariate analysis, history of cigarette smoking and pack-years of cigarette
smoking were predictors of IA detection, and a higher level of education and having
graduated from high school were associated with a decreased risk (Table 2). In a
multivariate analysis, independent predictors of detection of IA included female sex (OR
2.46), pack-years of cigarette smoking (OR 3.24 for 20 pack-years of cigarette smoking
compared with never having smoked), and duration of hypertension (OR 1.26 when
comparing those with 10 years of hypertension to those with no hypertension; Table 3).
The characteristics of the lesions detected (71 IAs among 58 patients) are summarized in
Table 4. Most of the aneurysms were small: 2 IAs were ≥7 mm in maximal diameter; 19
were 4–6 mm; and 50 were 2–3 mm. Aneurysms arose most commonly on the ICA, with 31
such lesions (8 OphA, and 23 other ICA), followed in frequency by the MCA (20), PCoA
(8), anterior cerebral artery (7), ACoA (3), and other locations (2).
During a mean follow-up period of 10 months (through September 1, 2006), of the 58
patients in whom aneurysms were detected, 10 patients (17%) underwent some form of
surgical or endovascular intervention for 11 aneurysms (Table 5). Overall, 5 aneurysms
were treated with clip ligation, 4 were treated with coils, and in 1 coil insertion was
attempted unsuccessfully and surgery is planned. In addition, a 2-mm OphA aneurysm was
wrapped in a patient with a 3-mm ACoA aneurysm that ruptured during follow-up.
Both of the aneurysms that were ≥ 7 mm in maximal diameter were treated. In the 17 people
with 4- to 6-mm aneurysms, in addition to the 4 with successful or attempted treatment, 4
others had confirmation of the IA on CT angiography and in 1 the lesion was confirmed on
MR angiography. In the 39 patients with 2- to 3-mm aneurysms, 4 lesions were treated, 7
were also noted on a CT angiogram, and 1 was noted on a repeated MR angiogram.
Overall, among the 58 patients followed for a mean of 10 months, through September 1,
2006, 1 rupture occurred in a 3-mm ACoA aneurysm 15 months after enrollment. Given the
single rupture among the 56 patients with aneurysms < 7 mm in diameter, the rupture risk
was 2% per year.
Discussion
It is apparent that there is an increased risk of IA detection among FDRs of patients
presenting with an IA. The degree of this increased risk, and in particular, predictors of an
increased possibility of IA detection, are not clear. The results of our study suggest that, in
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the FIA cohort among families with at least 2 members suffering from a brain aneurysm, in
the FDRs of those affected there is a relatively high risk of aneurysm detection on MR
angiography screening. Overall, aneurysms were detected in 19.1% of these “high-risk”
FDRs, a risk that was even higher in women than in men. This compares to a frequency of
detection in the general population of 1–2%.1 It is noteworthy that, in this research study, to
increase the cost-effectiveness of the MR angiography screening, only FDRs who were ≥ 30
years of age and who had a history of either hypertension or cigarette smoking were
screened with MR angiography. In a multivariate model, both duration of hypertension and
pack-years of cigarette smoking increased the risk of IA detection. For each 20 pack-years
of cigarette smoking compared to never having smoked, there was a >3-fold increased risk
of harboring an aneurysm (OR 3.24), and duration of hypertension also increased the risk,
with an OR of 1.26 when comparing those with 10 years of hypertension to those with no
hypertension. Sex was also important, with women being more than twice as likely to harbor
an aneurysm (OR 2.46).
These data can be compared with previously reported familial screening studies. In one
study of 438 individuals from 85 families without polycystic kidney disease, 38 (8.7%) had
an IA. Patients were screened if > 30 years of age and if they were an FDR of someone with
an IA.13 As was the case in the current study, most of the aneurysms detected were small. In
the earlier study, 41 (66.1%) of 62 aneurysms confirmed on DS angiography were ≤ 6 mm
in diameter, and 17 were > 7 mm in size. In the current study, only 2 (3%) of 58 aneurysms
were ≥ 7 mm in diameter. In the earlier study, aneurysms for which location was reported
were most commonly located on the MCA (33 [57%] of 58), a higher number than would
typically be expected. In the current study, 28% were MCA aneurysms, and 44% were ICA
aneurysms, which is typical of the distribution of unruptured IAs.7,19 Large screening
studies have also been performed in patients with sporadic SAH. Among 626 FDRs of 160
patients with sporadic SAH, 4% of them had aneurysms (25 of 626).10,12
Another feature of the aneurysms noted in the current study, as suggested previously, was
the frequency of multiple lesions, which were noted in 10 (17.2%) of 58 patients in the
current study. In a previous study of characteristics of IA in patients with familial SAH, the
authors noted that 26% of those with familial SAH had multiple aneurysms, compared with
10% of those with sporadic SAH.15 That study also noted that familial aneurysms were
generally larger at the time of the rupture, and the patients affected were more likely to have
multiple aneurysms than people with sporadic lesions. The size of the aneurysms associated
with hemorrhage cannot be defined from the current study because only 1, a small ACoA
aneurysm, hemorrhaged during the short course of follow-up.
Magnetic resonance angiography was the screening tool used for the current study. Previous
data support the suggestion that this is a valid screening tool for IA. The inter-observer
agreement in defining IA in asymptomatic patients is excellent, and more recent advances in
MR angiography have further improved this interobserver agreement, even among small
aneurysms.5,6 Intraarterial cerebral arteriography remains the gold standard for aneurysm
detection, but does entail a low risk of stroke and other complications. Arteriographic
confirmation of the aneurysm’s presence was not required for the current study.
Nevertheless, 26 of the patients did have confirmation of the aneurysm, either during coil
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embolization, at the time of surgical intervention, or via confirmatory arteriography or CT
angiography.
The available follow-up data for the current cohort reveal 1 aneurysm rupture during a short
period of follow-up (mean follow-up ~ 10 months). Considering that 1 patient among 56
with a < 7-mm aneurysm had a rupture during follow-up, this would lead to an annualized
rupture rate of 2%. This is higher than the 0.1% rupture risk among all unruptured
aneurysms 2–6 mm in diameter in the International Study of Unruptured Intracranial
Aneurysms.19 It is also noteworthy that another patient from a family with familial IA had
an aneurysm rupture prior to MR angiography screening.
There are several limitations of the current study. Because the patients selected for screening
were required to have either a history of hypertension or of cigarette smoking, these
particular data arise from a group of relatively “high-risk” FDRs. Cerebral arteriography was
not performed to confirm all aneurysms. It is recognized that there is an occurrence of false-
positive and false-negative aneurysm detection on MR angiograms, especially for very small
aneurysms. This is particularly important given that most of the aneurysms in this study
were 2–3 mm in diameter. In the current study, 8 of these small aneurysms were confirmed
at the time of either coil embolization (2 lesions), clip ligation (2), or arteriography (4). The
overall frequency of false positives (or false negatives) in this study is unknown because
arteriographic confirmation was not completed. In another familial IA screening study,13 of
the 43 DS angiograms performed to confirm the MR angiography findings, 7 (16%) of 43
were negative, with the suspected IA later found to be a vessel loop. It is noteworthy that the
prior study was performed > 10 years ago and that current MR angiography screening
probably has a higher specificity and sensitivity,5,6 even for very small aneurysms.
Healthcare providers are faced with the need to recommend optimum screening strategies
for patients who have familial IAs. Questions that follow in this circumstance include the
possibility of detecting an aneurysm in the affected relatives if 2 or more members of the
family are affected, and whether there are risk factors that increase the likelihood of
abnormal results on the screening study. In our study the findings support the suggestion that
among the FDRs of those affected, the risk of having an IA is considerable. The risk is
accentuated by a history of hypertension, of cigarette smoking, and in female FDRs. These
data further confirm that once an FDR of an affected patient reaches the age of 30 years, the
risk of harboring a brain aneurysm is high and screening should be strongly considered,
especially among women or those who either smoke or have hypertension. A key question
that remains unanswered is whether the familial IAs behave differently from nonfamilial
IAs. The short period of follow-up in the current study precludes definitive comment
regarding long-term natural history, and that will be clarified with ongoing follow-up.
Conclusions
In familial IAs, among the affected patients’ FDRs who are > 30 years of age, those who are
women or who have a history of smoking or hypertension are at increased risk of having a
brain aneurysm revealed on screening MR angiography. These data further suggest that
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these FDRs are at particularly high risk and should be strongly considered for aneurysm
screening.
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FIA Familial Intracranial Aneurysm
IA intracranial aneurysm
ICA internal carotid artery
MCA middle cerebral artery
MR magnetic resonance
OphA ophthalmic artery
OR odds ratio
PCoA posterior communicating artery
SAH subarachnoid hemorrhage
References
1. Atkinson JL, Sundt TM Jr, Houser OW, Whisnant JP. Angiographic frequency of anterior
circulation intracranial aneurysms. J Neurosurg. 1989; 70:551–555. [PubMed: 2926495]
2. Broderick JP, Sauerbeck LR, Foroud T, Huston J III, Pankratz N, Meissner I, et al. The Familial
Intracranial Aneurysm (FIA) study protocol. BMC Med Genet. 2005; 6:17. [PubMed: 15854227]
3. Chapman AB, Rubinstein D, Hughes R, Stears JC, Earnest MP, Johnson AM, et al. Intracranial
aneurysms in autosomal dominant polycystic kidney disease. N Engl J Med. 1992; 327:916–920.
[PubMed: 1513348]
4. Edwards A, Taylor GW. Ehlers-Danlos syndrome with vertebral artery aneurysm. Proc R Soc Med.
1969; 62:734–735. [PubMed: 5803529]
5. Gibbs GF, Huston J III, Bernstein MA, Riederer SJ, Brown RD Jr. Improved image quality of
intracranial aneurysms: 3.0-T versus 1.5-T time-of-flight MR angiography. AJNR Am J
Neuroradiol. 2004; 25:84–87. [PubMed: 14729534]
6. Gibbs GF, Huston J III, Bernstein MA, Riederer SJ, Brown RD Jr. 3.0-Tesla MR angiography of
intracranial aneurysms: comparison of time-of-flight and contrast-enhanced techniques. J Magn
Reson Imaging. 2005; 21:97–102. [PubMed: 15666402]
7. International Study of Unruptured Intracranial Aneurysms Investigators. Unruptured intracranial
aneurysms—risk of rupture and risks of surgical intervention. N Engl J Med. 1998; 339:1725–1733.
[PubMed: 9867550]
Brown et al. Page 8
J Neurosurg. Author manuscript; available in PMC 2014 October 08.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
8. Kissela BM, Sauerbeck L, Woo D, Khoury J, Carrozzella J, Pancioli A, et al. Subarachnoid
hemorrhage: a preventable disease with a heritable component. Stroke. 2002; 33:1321–1326.
[PubMed: 11988610]
9. Liang KY, Zeger SL. Longitudinal data analysis using general linear models. Biometrika. 1986;
73:13–22.
10. Magnetic Resonance Angiography in Relatives of Patients with Subarachnoid Hemorrhage Study
Group. Risks and benefits of screening for intracranial aneurysms in first-degree relatives of
patients with sporadic subarachnoid hemorrhage. N Engl J Med. 1999; 341:1344–1350. [PubMed:
10536126]
11. Maher CO, Piepgras DG, Brown RD Jr, Friedman JA, Pollock BE. Cerebrovascular manifestations
in 321 cases of hereditary hemorrhagic telangiectasia. Stroke. 2001; 32:877–882. [PubMed:
11283386]
12. Raaymakers TW. Aneurysms in relatives of patients with sub-arachnoid hemorrhage: frequency
and risk factors. MARS Study Group. Magnetic Resonance Angiography in Relatives of patients
with Subarachnoid hemorrhage. Neurology. 1999; 53:982–988. [PubMed: 10496256]
13. Ronkainen A, Hernesniemi J, Puranen M, Niemitukia L, Vanninen R, Ryynanen M, et al. Familial
intracranial aneurysms. Lancet. 1997; 349:380–384. [PubMed: 9033463]
14. Ronkainen A, Miettinen H, Karkola K, Papinaho S, Vanninen R, Puranen M, et al. Risk of
harboring an unruptured intracranial aneurysm. Stroke. 1998; 29:359–362. [PubMed: 9472874]
15. Ruigrok YM, Rinkel GJ, Algra A, Raaymakers TW, Van Gijn J. Characteristics of intracranial
aneurysms in patients with familial subarachnoid hemorrhage. Neurology. 2004; 62:891–894.
[PubMed: 15037688]
16. Schievink WI. Genetics and aneurysm formation. Neurosurg Clin N Am. 1998; 9:485–495.
[PubMed: 9668181]
17. Schievink WI. Marfan syndrome and intracranial aneurysms. Stroke. 1999; 30:2767–2768.
[PubMed: 10583939]
18. Schievink WI, Schaid DJ, Michels VV, Piepgras DG. Familial aneurysmal subarachnoid
hemorrhage: a community-based study. J Neurosurg. 1995; 83:426–429. [PubMed: 7666217]
19. Wiebers DO, Whisnant JP, Huston J III, Meissner I, Brown RD Jr, Piepgras DG, et al. Unruptured
intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular
treatment. Lancet. 2003; 362:103–110. [PubMed: 12867109]
Appendix
Clinical Centers—University of Alabama at Birmingham: W. Fisher (principal investigator
[PI]); H. Forson, coordinator
Clinical Trials Research Unit, University of Auckland and Auckland City Hospital, New
Zealand: C. Anderson (PI); E. Mee (PI); C. Howe, coordinator; S. Vos, coordinator
Royal Perth Hospital, Sir Charles Gairdner Hospital, Royal Adelaide Hospital, Royal
Melbourne Hospital, Alfred Hospital, West-mead Hospital, Royal North Shore Hospital,
Royal Prince Alfred Hospital, Australia: C. Anderson (PI); G. Hankey (PI); N. Knuckey
(PI); J. Laidlaw (PI); P. Reilly (PI); N. Dorsch (PI); M. Morgan (PI); M. Besser (PI); J.
Rosenfeld (PI); K. Athanasiadis, coordinator; A. Claxton, coordinator; V. Dunne,
coordinator; J. Griffith, coordinator; J. Davidson, coordinator; S. Pope, coordinator; Amanda
Froelich, coordinator
Brigham and Women’s Hospital: A. Day (PI); R. Brach, coordinator
University of Cincinnati: D. Woo (co-PI); M. Zuccarello (co-PI); A. Ringer (co-PI); H. Yeh
(co-PI); K. Franklin, coordinator
Brown et al. Page 9
J Neurosurg. Author manuscript; available in PMC 2014 October 08.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Cleveland Clinic Foundation: P. Ramussen (PI); D. Andrews-Hinders, coordinator; T.
Wheeler, coordinator
Columbia University: E. S. Connolly (PI); R. Sacco (co-PI); D. LaMonica, coordinator
University of Florida: S. B. Lewis (PI); A. Royster, coordinator
Indianapolis Neurosurgical Group: T. Payner (PI); N. Miracle, coordinator
Johns Hopkins University: K. Murphy (PI); B. Kohler, coordinator
Massachusetts General Hospital: C. Ogilvy (PI); D. Buckley, coordinator; J. Manansala,
coordinator
London Health Science Center Research, Inc.: G. Ferguson (PI); C. Mayer, coordinator; J.
Peacock, coordinator
Notre Dame Hospital: G. Rouleau (PI); A. Desjarlais, coordinator
University of Maryland: E. F. Aldrich (PI); C. Aldrich, coordinator; C. Byard, coordinator
Mayo Clinic: R. D. Brown (PI); L. Jaeger, coordinator
University of Michigan: L. Morgenstern (PI); M. Concannon, coordinator
New Jersey Medical School: A. I. Qureshi (PI); P. Harris-Lane, coordinator
Northwestern University: H. Batjer (PI); G. Joven, S. Thompson, coordinators
University of Ottawa: M. T. Richard (PI); A. Hopper (PI)
University of Pittsburgh: A. B. Kassam (PI); K. Lee, coordinator
University of California, San Francisco: C. Johnston (PI); K. Katsura, coordinator
University of Southern California: S. Giannotta (PI); D. Fishback, coordinator
Stanford University Medical Center: G. Steinberg (PI); D. Luu, coordinator; M. Coburn,
coordinator
University of Texas at Houston: M. Malkoff (PI); A. Wojner, coordinator
University of Virginia: N. Kassell (PI); B. Worrall (co-PI); G. Radakovic, coordinator
University of Washington: D. Tirschwell (PI); P. Tanzi, coordinator
Washington University: C. Derdeyn (PI); M. Catanzaro, coordinator
University of Manitoba (Winnipeg): A. Kaufmann (PI); D. Gladish, coordinator
Brown et al. Page 10
J Neurosurg. Author manuscript; available in PMC 2014 October 08.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Fig. 1.
Preoperative MR angiogram (A) and DS angiogram (B) demonstrating a 2-mm ACoA
aneurysm (arrows), which was successfully treated with coil embolization. Magnetic
resonance angiogram (C) and DS angiogram (D) obtained in another patient of a wide-
necked 2-mm aneurysm on the left M1 branch.
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TABLE 2
Analysis of selected risk factors as potential predictors of aneurysm detection on MR angiography screening*
Risk Factor OR† SE p Value
age at interview (per yr) 1.02 0.010 0.097
age
 age (40–60 yrs) compared to <40 yrs 1.14 0.259 0.606
 age (>60 yrs) compared to <40 yrs 1.09 0.280 0.763
history of hypertension 1.02 0.242 0.845
duration of hypertension (per yr) 1.02 0.012 0.093
ever smoked cigarettes 2.85 0.401 0.009
cigarette smoking pack-years (per yr) 1.01 0.004 0.007
ever smoked cigars 0.18 0.992 0.083
ever used alcohol 0.77 0.257 0.317
alcohol (drinks/day) 0.85 0.099 0.107
caffeine (cups/day) 1.02 0.025 0.380
excessive caffeine (>4 cups/day) 1.07 0.270 0.808
marijuana use 1.13 0.370 0.735
diabetes 1.70 0.400 0.187
high cholesterol 0.83 0.247 0.457
body mass index 0.98 0.027 0.545
estrogen replacement therapy‡ 1.30 0.258 0.313
currently married 1.25 0.296 0.448
highest grade completed (per grade completed) 0.89 0.043 0.006
high-school graduate 0.57 0.269 0.039
sex (F) 2.07 0.280 0.009
*SE = standard error.
†Odds ratios per unit (or, when applicable, analysis is of risk factor history in comparison to those without a history of the factor).
‡
Restricted to female participants.
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TABLE 3
Multivariate analysis of selected factors as potential predictors of aneurysms detected on MR angiography
screening*
Risk Factor OR (95% CI) SE p Value
log (pack-years of cigarette smoking) 3.24† (1.81–5.79) 0.072 <0.001
sex 2.46‡ (1.46–4.54) 0.290 0.001
duration of hypertension 1.26§ (1.07–1.49) 0.009 0.006
*CI = confidence interval.
†Odds ratio for 20 pack-years of cigarette smoking compared to never having smoked.
‡Odds ratio for females compared to males.
§Odds ratio for 10 years of hypertension compared to no hypertension.
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TABLE 4
Characteristics of aneurysms detected*
Characteristic No. of Patients (%) No. of Aneurysms (%)
size (diameter of largest aneurysm; 58 patients)
max diameter (mm)
 ≥7 2 (3)
 4–6 17 (29)
 2–3 39 (67)
size (all aneurysms; 71 lesions)
max diameter (mm)
 ≥7 2 (3)
 4–6 19 (27)
 2–3 50 (70)
location (all aneurysms; 71 lesions)
artery of origin
 ICA 31 (44)
  OphA 8 (11)
  other ICA 23 (32)
 MCA 20 (28)
 PCoA 8 (11)
 ACA 7 (10)
 ACoA 3 (4)
 other 2 (3)
*ACA = anterior cerebral artery.
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TABLE 5
Aneurysms detected on MR angiography screening: short-term management and outcome*
Case No. Aneurysm Site Size (mm) Treatment
1 rt ICA 7 clip ligation
2 lt OphA 8 coil insertion
3 rt MCA 4 aneurysm growth on later MR angio, clip ligation
4 ACoA 3 ruptured & then clip ligation
rt OphA 2 wrapped
5 ACoA 2 coil-treated
6 SCA 2 coil-treated
7 lt MCA 5 attempted coil insertion unsuccessful; op planned
8 rt PCoA 4 coil-treated
9 lt MCA 5 clip ligation
10 lt MCA 2 clip ligation
*
Eleven lesions in 10 patients were treated surgically, and 60 aneurysms in 48 patients were managed conservatively. Abbreviations: angio =
angiography; SCA = superior cerebellar artery.
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